Search for Clinical Trial Results
Diphtheria - 25 Studies Found
Status | Study |
Completed |
Study Name: Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older Condition:
|
Recruiting |
Study Name: Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS Condition:
|
Recruiting |
Study Name: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women Condition: Diphtheria-Tetanus-acellular Pertussis Vaccines Date: 2015-02-26 Interventions:
|
Completed |
Study Name: Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years Condition:
|
Completed |
Study Name: Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination Condition:
Date: 2005-10-25 Interventions: Biological: DTP3/4+OPV+MV versus OPV+MV or DTP4+OPV4 versus OPV4 Trial of not providing 3. and/or 4. DTP |
Not yet recruiting |
Study Name: Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly Condition: Heterologous Effects of Vaccines Date: 2016-05-03 Interventions:
|
Completed |
Study Name: REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-Old Children Condition:
|
Completed |
Study Name: Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children Condition: Haemophilus Influenzae Type b (Hib) Infection Date: 2010-05-14 Interventions:
|
Completed |
Study Name: Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age Condition:
Date: 2007-09-04 Interventions: Biological: Tetanus and diphtheria toxoids and acellular pertussis 0.5 mL, Intramuscular |
Completed |
Study Name: Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults Condition:
|